← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

M

$ Value

$0

Shares

2,120

Price

$0

Filed

Jun 23

Insider

Name

Ho Maykin

Title

CIK

0001646395

Roles

Director

Transaction Details

Transaction Date

2025-06-20

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. | The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested. | These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026. | The restricted stock units were granted on June 20, 2024. The shares underlying the stock units vest in full on June 20, 2025. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Filing Info

Accession No.

0001439222-25-000053

Form Type

4

Issuer CIK

0001439222

Ho Maykin's History

Date Ticker Type Value
2025-06-20 AGIO M $0
2025-06-20 AGIO M $0
2025-06-18 AGIO A $0
2025-06-18 AGIO A $0
2025-06-04 FGEN A $0
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA A
2025-05-28 NMRA A

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$662K 2026-04-02
Jones Cecilia
Chief Financial Officer
$109K 2026-04-02
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$114K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$103K 2026-04-02